Response to: "Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature".
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2139, doi. 10.1007/s00198-021-06092-1
- By:
- Publication type:
- Article
Works matching IS 0937941X AND DT 2021 AND VI 32 AND IP 10
Results: 30
1
2
Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
3
Correction to: The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
4
Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2131, doi. 10.1007/s00198-021-06033-y
- By:
- Publication type:
- Article
5
Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1937, doi. 10.1007/s00198-021-05997-1
- By:
- Publication type:
- Article
6
Denosumab is not associated with risk of malignancy? More evidence is needed.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2133, doi. 10.1007/s00198-021-05988-2
- By:
- Publication type:
- Article
7
A cautionary case: osteoporotic femur fracture after robotic-assisted total knee arthroplasty.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2125, doi. 10.1007/s00198-021-05977-5
- By:
- Publication type:
- Article
8
Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2115, doi. 10.1007/s00198-021-05971-x
- By:
- Publication type:
- Article
9
Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1911, doi. 10.1007/s00198-021-05961-z
- By:
- Publication type:
- Article
10
How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1921, doi. 10.1007/s00198-021-05957-9
- By:
- Publication type:
- Article
11
Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2073, doi. 10.1007/s00198-021-05955-x
- By:
- Publication type:
- Article
12
Asymptomatic elevated parathyroid hormone level due to immunoassay interference.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2111, doi. 10.1007/s00198-021-05950-2
- By:
- Publication type:
- Article
13
Physical capability, physical activity, and their association with femoral bone mineral density in adults aged 40 years and older: The Tromsø study 2015–2016.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2083, doi. 10.1007/s00198-021-05949-9
- By:
- Publication type:
- Article
14
Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2119, doi. 10.1007/s00198-021-05948-w
- By:
- Publication type:
- Article
15
Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2095, doi. 10.1007/s00198-021-05947-x
- By:
- Publication type:
- Article
16
An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines: A report for the National Osteoporosis Guideline Group (NOGG).
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1951, doi. 10.1007/s00198-021-05942-2
- By:
- Publication type:
- Article
17
Height loss in postmenopausal women—do we need more for fracture risk assessment? Results from the GO Study.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2043, doi. 10.1007/s00198-021-05941-3
- By:
- Publication type:
- Article
18
Health care utilization and excess costs after pelvic fractures among older people in Germany.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2061, doi. 10.1007/s00198-021-05935-1
- By:
- Publication type:
- Article
19
Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2105, doi. 10.1007/s00198-021-05933-3
- By:
- Publication type:
- Article
20
Efficiently stratifying mid-term death risk in femoral fractures in the elderly: introducing the ASAgeCoGeCC Score.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2023, doi. 10.1007/s00198-021-05932-4
- By:
- Publication type:
- Article
21
Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2011, doi. 10.1007/s00198-021-05927-1
- By:
- Publication type:
- Article
22
High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2051, doi. 10.1007/s00198-021-05926-2
- By:
- Publication type:
- Article
23
Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1999, doi. 10.1007/s00198-021-05925-3
- By:
- Publication type:
- Article
24
Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD).
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1989, doi. 10.1007/s00198-021-05922-6
- By:
- Publication type:
- Article
25
Impact of population-based or targeted BMD interventions on fracture incidence.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1973, doi. 10.1007/s00198-021-05917-3
- By:
- Publication type:
- Article
26
Higher latitude and lower solar radiation influence on hip fracture admissions in Chilean older population.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2033, doi. 10.1007/s00198-021-05910-w
- By:
- Publication type:
- Article
27
Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1981, doi. 10.1007/s00198-021-05907-5
- By:
- Publication type:
- Article
28
The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 1961, doi. 10.1007/s00198-021-05890-x
- By:
- Publication type:
- Article
29
Clarification of some issues using Bayesian methods and model selection in meta-analysis and reporting.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2137, doi. 10.1007/s00198-021-05844-3
- By:
- Publication type:
- Article
30
Letter to the Editor about the article "C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches".
- Published in:
- Osteoporosis International, 2021, v. 32, n. 10, p. 2135, doi. 10.1007/s00198-020-05750-0
- By:
- Publication type:
- Article